医学
阿达木单抗
英夫利昔单抗
治疗药物监测
炎症性肠病
药品
重症监护医学
疾病
克罗恩病
维多利祖马布
炎症性肠病
生物制剂
溃疡性结肠炎
内科学
生物仿制药
药理学
作者
Xavier Roblin,Robert D. Little,Nicolas Mathieu,Stéphane Paul,Stéphane Nancey,Mathide Barrau,Miles Sparrow
标识
DOI：10.1080/17474124.2024.2409300
摘要
Introduction Therapeutic Drug Monitoring (TDM) has an important role in the management of inflammatory bowel disease (IBD) patients on infliximab (IFX) or adalimumab and is recommended in IBD patients presenting a loss of response under anti TNF agent. But, TDM was not recommended for others biotherapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI
冰魂
SYLH
孙燕
爱静静
jenningseastera
平常的毛豆
一一
昏睡的蟠桃
iNk
eric888
ECUST
coolkid
8R60d8
cctv18
眯眯眼的衬衫
MchemG
HEIKU
xzy998
风清扬
pcr163
皖公网安备34019202002308
